BFEC
RVMD icon

Benjamin F. Edwards & Company’s Revolution Medicines RVMD Stock Holding History

Benjamin F. Edwards & Company’s Portfolio RVMD Stock Details RVMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		$2K Sell
56
-106
-65% -$3.96K ﹤0.01% 2058
2024
Q1 		$5K Buy
+162
New +$4.8K ﹤0.01% 1881

Other funds holding RVMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
AI
Alphabet Inc Mountain View, California $99.1B AUM 124.46% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return

Benjamin F. Edwards & Company's RVMD Position: Q2 2024 in Review

Benjamin F. Edwards & Company reduced its Revolution Medicines (RVMD) stake by 65% in Q2 2024, selling an estimated $3.96K and leaving 56 shares worth $2K. The position accounts for ﹤0.01% of the portfolio, ranked #2058.

Benjamin F. Edwards & Company first reported a position in RVMD in Q1 2024 and has held it in 2 quarters since. The position peaked at $5K in Q1 2024. 223 funds tracked by Wall St. Rank hold RVMD as of Q2 2024.

  • Benjamin F. Edwards & Company held 56 shares of Revolution Medicines worth $2K as of Q2 2024.
  • Benjamin F. Edwards & Company sold 106 Revolution Medicines shares in Q2 2024, an estimated $3.96K.
  • Revolution Medicines made up ﹤0.01% of Benjamin F. Edwards & Company's portfolio in Q2 2024, its #2058 holding.
  • Benjamin F. Edwards & Company first reported a position in Revolution Medicines in Q1 2024 and has held it in 2 quarters since.
  • Benjamin F. Edwards & Company's Revolution Medicines position peaked at $5K in Q1 2024.
  • 223 funds tracked by Wall St. Rank held Revolution Medicines as of Q2 2024.

Based on Benjamin F. Edwards & Company's 13F filing for Q2 2024, filed 12 Aug 2024.